The 12 closest competitors and alternatives to Faron Pharmaceuticals Oy among health care companies — ranked by similarity to what Faron Pharmaceuticals Oy actually does, not by market-cap band.
Subscribe to see Faron Pharmaceuticals Oy’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company that develops novel immunotherapies and macrophage-targeting treatments for cancer patients. Its lead candidate, bexmarilimab, is an anti-Clever-1 antibody being evaluated in clinical trials for hematological cancers and solid tumors to improve the efficacy of standard cancer treatments.
Faron Pharmaceuticals Oy is a health care company headquartered in Finland. Xcout tracks 6 named people at Faron Pharmaceuticals Oy, including Tuomo Pätsi (Non-Executive Chairman).
Ranked by semantic similarity — how close each company is to Faron Pharmaceuticals Oy by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthcare
Forty Seven, Inc. is a clinical-stage immuno-oncology company headquartered in Menlo Park, California, that develops therapies targeting cancer immune evasion pathways.
Healthcare
Harbour BioMed is a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology.
Similar health care company
Spago Nanomedical is a clinical-stage pharmaceutical company that develops precision nanomedicine products for the diagnosis and treatment of cancer and other severe diseases. Its pipeline includes Tumorad, a targeted radionuclide therapy for various cancers, and SpagoPix, a polymeric contrast agent designed to improve the precision of MRI diagnostics.
Healthcare
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Similar health care company
Orion Oyj is a pharmaceutical and healthcare company that develops, manufactures, and markets medicines, active pharmaceutical ingredients, self-care products, and animal health products. The company serves patients, healthcare professionals, and animal owners by focusing on therapeutic areas such as oncology, respiratory diseases, neurology, women's health, and pain management.
Biotechnology
Carisma Therapeutics is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on discovering and developing engineered macrophage-based immunotherapies.
Biotechnology
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Biotech
TILT Biotherapeutics is a Finnish biotechnology company developing tumor-targeted immunotherapies, including oncolytic adenoviruses designed to stimulate immune responses against solid tumors. Its therapies are intended for cancer patients and are developed through clinical and pharmaceutical partnerships.
Life Sciences
Northern Biologics is a biotechnology company developing antibody-based therapeutics, with a focus on treating cancer and targeting the tumor microenvironment. Its products are intended for oncology patients and clinical partners in the biopharmaceutical sector.
Biotechnology
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Biotechnology / Pharmaceuticals
Symphogen, part of the Servier Group, operates as an Antibody Center of Excellence focusing on oncology and immuno-oncology. The company utilizes an antibody discovery and research platform to develop monoclonal antibody therapeutics aimed at improving treatments for cancer patients.
Biotech
Immatics is a biopharmaceutical company that develops T cell-based immunotherapies and bispecific product candidates to treat various types of cancer. The company focuses on precision targeting of the PRAME protein expressed in multiple solid tumors, serving cancer patients with high unmet medical needs.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Faron Pharmaceuticals Oyand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →